- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Nature Communications 11.2020, Article 3841
- Ereignis
-
Veröffentlichung
- (wo)
-
Furtwangen
- (wer)
-
Hochschule Furtwangen
- (wann)
-
2020
- Urheber
-
Werbeck, Nicolas
Shukla, Vaibhav K.
Kunze, Micha B.
Yalinca, Havva
Pritchard, Ruth B.
Siemons, Lucas
Mondal, Somnath
Greenwood, Simon O.
Kirkpatrick, John
Marson, Charles M.
Flemming Hansen, Dennis
- DOI
-
10.1038/s41467-020-17610-w
- URN
-
urn:nbn:de:bsz:fn1-opus4-71447
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:46 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Werbeck, Nicolas
- Shukla, Vaibhav K.
- Kunze, Micha B.
- Yalinca, Havva
- Pritchard, Ruth B.
- Siemons, Lucas
- Mondal, Somnath
- Greenwood, Simon O.
- Kirkpatrick, John
- Marson, Charles M.
- Flemming Hansen, Dennis
- Hochschule Furtwangen
Entstanden
- 2020
Ähnliche Objekte (12)
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Development of class IIa histone deacetylase inhibitors
Modulation of posttranscriptional and posttranslational regulatory processes by histone deacetylase inhibitors
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma
Role of histone deacetylase 11 in neuroblastoma
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Nitric oxide affects histone acetylation by inhibiting histone deacetylase activity in Arabidopsis
Selectivity in histone deacetylase inhibition: A biophysical approach
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Targeting aberrant histone acetylation in cancer: development of class I selective histone deacetylase (HDAC) inhibitors and dual HDAC/BET bromodomain inhibitors
Role of histone deacetylase 9 isoforms in pulmonary fibrosis
Hypothalamic leptin action is mediated by histone deacetylase 5
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Development of class IIa histone deacetylase inhibitors
Modulation of posttranscriptional and posttranslational regulatory processes by histone deacetylase inhibitors
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma
Role of histone deacetylase 11 in neuroblastoma
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Nitric oxide affects histone acetylation by inhibiting histone deacetylase activity in Arabidopsis
Selectivity in histone deacetylase inhibition: A biophysical approach
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Targeting aberrant histone acetylation in cancer: development of class I selective histone deacetylase (HDAC) inhibitors and dual HDAC/BET bromodomain inhibitors
Role of histone deacetylase 9 isoforms in pulmonary fibrosis
Hypothalamic leptin action is mediated by histone deacetylase 5
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Development of class IIa histone deacetylase inhibitors
Modulation of posttranscriptional and posttranslational regulatory processes by histone deacetylase inhibitors
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma
Role of histone deacetylase 11 in neuroblastoma
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Nitric oxide affects histone acetylation by inhibiting histone deacetylase activity in Arabidopsis
Selectivity in histone deacetylase inhibition: A biophysical approach
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Targeting aberrant histone acetylation in cancer: development of class I selective histone deacetylase (HDAC) inhibitors and dual HDAC/BET bromodomain inhibitors
Role of histone deacetylase 9 isoforms in pulmonary fibrosis